Works matching Purdue Pharma LP

Results: 90

Blame or discovery? Walter Benjamin's Jetztzeit, Purdue Pharma LP and 'our values and our historical understanding of psychiatrists'.

Published in:

BJPsych Bulletin, 2024, v. 48, n. 2, p. 121, doi. 10.1192/bjb.2023.39

By:

Ikkos, George

Publication type:

Article

Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.

Published in:

Journal of Health Politics, Policy & Law, 2022, v. 47, n. 4, p. 453, doi. 10.1215/03616878-9716712

By:

Yakubi, Hanna;
Gac, Brian;
Apollonio, Dorie E.

Publication type:

Article

The Responsible Corporate Officer, the DeCosters, and the Opioid Epidemic: Why Prison Sentences Based on the RCO Doctrine Do Not Violate Due Process.

Published in:

Journal of Corporation Law, 2020, v. 46, n. 2, p. 483

By:

Murray, Stacey

Publication type:

Article

Acetaminophen's maximum dosage yields unexpected result.

Published in:

American Journal of Health-System Pharmacy, 2006, v. 63, n. 17, p. 1581, doi. 10.2146/news060006

By:

Thompson, Cheryl A.

Publication type:

Article

FDA embraces RFID to protect drug supply.

Published in:

American Journal of Health-System Pharmacy, 2004, v. 61, n. 24, p. 2612, doi. 10.1093/ajhp/61.24.2612

By:

Young, Donna

Publication type:

Article

PURDUE PHARMA AND SHIONOGI TO COLLABORATE ON ANALGESIC RESEARCH AND MARKETING.

Published in:: Journal of Pain & Palliative Care Pharmacotherapy, 2006, v. 20, n. 3, p. 111
Publication type:: Article

From the FDA.

Published in:: Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 8, p. 8
Publication type:: Article

Buprenorphine transdermal system has REMS.

Published in:

American Journal of Health-System Pharmacy, 2010, v. 67, n. 16, p. 1306, doi. 10.2146/news100055

By:

Thompson, Cheryl A.

Publication type:

Article

Debt-Free Bankruptcy: THE PROS AND CONS OF LITIGATING MASS TORT LITIGATION THROUGH BANKRUPTCY.

Published in:

Judges' Journal, 2022, v. 61, n. 4, p. 8

By:

O'Farrell, Leah A.

Publication type:

Article

General Release Signed by Qui Tam Relator Does Not Bar Later Suits By Other Relators Alleging the Same Fraud - United States ex rel. May v. Purdue Pharma L.P.

Published in:

American Journal of Law & Medicine, 2014, v. 40, n. 1, p. 175, doi. 10.1017/s0098858800000095

By:

Fine, Hannah

Publication type:

Article

PHARMACY CORNER.

Published in:

Oncology Nursing Forum, 2000, v. 27, n. 8, p. 1299

By:

Mitchell, Sandra A.

Publication type:

Article

AROUND THE GLOBE.

Published in:: Australian Journal of Pharmacy, 2018, v. 99, p. 10
Publication type:: Article

The Opioid Litigation's Challenge for Tort Theory.

Published in:

Brooklyn Law Review, 2025, v. 90, n. 4, p. 1103

By:

Lemann, Alexander B.

Publication type:

Article

Big Pharma and Physician Education.

Published in:

2016

By:

Dreyfus, Robert;
Fawcett, Jan

Publication type:

Letter to the Editor

Purdue vEndo: ‘It ain’t over till it’s over’.

Published in:

Journal of Generic Medicines, 2006, v. 3, n. 3, p. 226, doi. 10.1057/palgrave.jgm.4940123

By:

Rein, Frederick H.

Publication type:

Article

THE WEATHERVANE.

Published in:

2007

By:

Stodd, Russell T.

Publication type:

Editorial

Against Bankruptcy Exceptionalism.

Published in:

University of Chicago Law Review, 2022, v. 89, n. 8, p. 1925

By:

Seymour, Jonathan M.

Publication type:

Article

From Absolution to Accountability.

Published in:

Boston Review, 2019, v. 44, n. 2, p. 49

By:

Kauffman, L. A.

Publication type:

Article

How Race Made the Opioid Crisis.

Published in:

Boston Review, 2019, v. 44, n. 2, p. 7

By:

March, Donna

Publication type:

Article

Erratum.

Published in:: 2010
Publication type:: Correction Notice

The Rule of the Deal: Bankruptcy Bargains and Other Misnomers.

Published in:

American Bankruptcy Law Journal, 2023, v. 97, n. 1, p. 41

By:

Lipson, Jonathan C.

Publication type:

Article

"A Bitter Result": Purdue Pharma, a Sackler Bankruptcy Filing, and Improving Monetary and Nonmonetary Recoveries in Mass Tort Bankruptcies.

Published in:

American Bankruptcy Law Journal, 2022, v. 96, n. 2, p. 361

By:

Organek, William

Publication type:

Article

It's Time to Finish What They Started: How Purdue Pharma and the Sackler Family Can Help End the Opioid Epidemic.

Published in:

Penn State Law Review, 2020, v. 125, n. 1, p. 255

By:

Edgell, Caitlyn

Publication type:

Article

PURDUE PHARMA L.P. V. FAULDING INC.

Published in:

Berkeley Technology Law Journal, 2002, v. 17, n. 1, p. 95

By:

Limin Zheng

Publication type:

Article

Finally, the Sackler Family in the Legal Crosshairs.

Published in:

Appalachian Journal, 2018, v. 46, n. 1/2, p. 25

By:

Mulvihill, Geoff

Publication type:

Article

Purdue appeals OxyContin patents.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 2, p. 106, doi. 10.1038/nrd1316
Publication type:: Article

Civil Litigation and the Opioid Epidemic: The Role of Courts in a National Health Crisis.

Published in:

Journal of Law, Medicine & Ethics, 2018, v. 46, n. 2, p. 351, doi. 10.1177/1073110518782945

By:

Gluck, Abbe R.;
Hall, Ashley;
Curfman, Gregory

Publication type:

Article

BIG TOBACCO'S BIG SETTLEMENT: WHAT PHARMACEUTICAL COMPANIES CAN LEARN TO PROTECT THEMSELVES IN OPIOID LITIGATION.

Published in:

University of Louisville Law Review, 2021, v. 60, n. 1, p. 161

By:

Leichhardt, Mason A.

Publication type:

Article

PRODUCT HOPPING 2.0: GETTING THE FDA TO YANK YOUR ORIGINAL LICENSE BEATS STACKING PATENTS.

Published in:

Marquette Intellectual Property Law Review, 2015, v. 19, n. 2, p. 161

By:

NOAH, LARS

Publication type:

Article

THE END(S) OF BANKRUPTCY EXCEPTIONALISM: PURDUE PHARMA AND THE PROBLEM OF SOCIAL DEBT.

Published in:

Cardozo Law Review, 2025, v. 46, n. 3, p. 861

By:

Lipson, Jonathan C.;
Foohey, Pamela

Publication type:

Article

In re Purdue Pharma L. P.: The Second Circuit Justifies the Equitable Authority to Impose Non-Debtor Releases in a Controversial Compromise.

Published in:

Tulane Law Review, 2024, v. 98, n. 4, p. 709

By:

Guidry, André

Publication type:

Article

Oxycodone cases.

Published in:: Canadian Medical Association Journal (CMAJ), 2005, v. 172, n. 11, p. 1432
Publication type:: Article

OxyContin class-action suit to proceed.

Published in:: Canadian Medical Association Journal (CMAJ), 2003, v. 169, n. 7, p. 699
Publication type:: Article

Purdue considering naloxone to curb OxyContin abuse.

Published in:: Brown University Psychopharmacology Update, 2001, v. 12, n. 11, p. 8
Publication type:: Article

Hippocrates and Targin.

Published in:

2016

By:

Lexchin, Joel

Publication type:

Letter

OxyContin and a Regulation Deficiency of the Pharmaceutical Industry: Rethinking State-Corporate Crime.

Published in:

Critical Criminology, 2011, v. 19, n. 3, p. 213, doi. 10.1007/s10612-010-9113-9

By:

Griffin, O.;
Miller, Bryan

Publication type:

Article

OxyContin, prescription opioid abuse and economic medicalization.

Published in:

Medicolegal & Bioethics, 2012, v. 2, p. 31, doi. 10.2147/MB.S32040

By:

Poitras, Geoffrey

Publication type:

Article

Designing Designer Bankruptcy.

Published in:

Texas Law Review, 2024, v. 102, n. 6, p. 1205

By:

Francus, Michael A.

Publication type:

Article

"Special": Remedial Schemes in Mass Tort Bankruptcies.

Published in:

Texas Law Review, 2023, v. 101, n. 7, p. 1773

By:

Lipson, Jonathan C.

Publication type:

Article

Purdue's Poison Pill: The Breakdown of Chapter 11's Checks and Balances.

Published in:

Texas Law Review, 2022, v. 100, n. 6, p. 1079

By:

Levitin, Adam J.

Publication type:

Article

Afghanistan and the Purdue Pharma Case are Reminders That the U.S. is a Failed Narco-State, Too.

Published in:

CounterPunch, 2021, p. 1

By:

Eskow, Richard

Publication type:

Article

OPIOID LAWSUITS: IS THERE ANY END IN SIGHT?

Published in:

Health Matrix: Journal of Law-Medicine, 2023, v. 33, p. 193

By:

Ausness, Richard C.

Publication type:

Article

A Trojan Horse Inside the Gates? Knowledge Spillovers During Patent Litigation.

Published in:

Academy of Management Journal, 2022, v. 65, n. 5, p. 1747, doi. 10.5465/amj.2018.1181

By:

Awate, Kiran S.;
Makhija, Mona

Publication type:

Article

Our Opium Wars.

Published in:

Third Text, 2018, v. 32, n. 5/6, p. 662, doi. 10.1080/09528822.2018.1559169

By:

Haiven, Max

Publication type:

Article

Modulation of voltage-gated sodium channels hyperpolarizes the voltage threshold for activation in spinal motoneurones.

Published in:

Experimental Brain Research, 2012, v. 217, n. 2, p. 311, doi. 10.1007/s00221-011-2994-3

By:

Power, Kevin;
Carlin, Kevin;
Fedirchuk, Brent

Publication type:

Article

Comparison of the 17α-Hydroxylase/C17,20-Lyase Activities of Porcine, Guinea Pig and Bovine P450c17 Using Purified Recombinant Fusion Proteins Containing P450c17 Linked to NADPH-P450 Reductase.

Published in:

Drug Metabolism Reviews, 2007, v. 39, n. 2/3, p. 289, doi. 10.1080/03602530701468391

By:

Shet, Manjunath S.;
Fisher, Charles W.;
Tremblay, Yves;
Belanger, Alain;
Conley, Alan J.;
Ian Mason, J.;
Estabrook, Ronald W.

Publication type:

Article

Relevance of Cytochrome P450s in Plants: Also One of Ron Estabrook's Research Interests.

Published in:

Drug Metabolism Reviews, 2007, v. 39, n. 2/3, p. 273, doi. 10.1080/03602530701468268

By:

Shet, Manjunath S.

Publication type:

Article

Phenylarsine oxide as a redox modulator of transient receptor potential vanilloid type 1 channel function.

Published in:

Journal of Neuroscience Research, 2015, v. 93, n. 2, p. 309, doi. 10.1002/jnr.23479

By:

Carlin, Kevin P.;
Wu, Gang;
Patel, Aniket;
Crumley, Gregg;
Ilyin, Victor I.

Publication type:

Article

Drivers and Barriers to Tolerable and Effective Treatment for ADHD: The Importance of Treatment Perseverance and Duration of Effect.

Published in:

Journal of Attention Disorders, 2024, v. 28, n. 3, p. 310, doi. 10.1177/10870547231217088

By:

Way, Nate;
Mikl, Jaromir;
Cataldo, Marc;
Erensen, Jennifer G.;
Martin, Ashley;
Li, Vicky;
Pliszka, Steven R.

Publication type:

Article

Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.

Published in:

Addiction, 2017, v. 112, n. 9, p. 1647, doi. 10.1111/add.13849

By:

Mundin, Gill;
McDonald, Rebecca;
Smith, Kevin;
Harris, Stephen;
Strang, John

Publication type:

Article